1,2:5,6-di-O-isopropylidene-3-deoxy-3-(methoxycarbonyl-methyl)-α-D-allofuranoside | 18427-18-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1,2:5,6-di-O-isopropylidene-3-deoxy-3-(methoxycarbonyl-methyl)-α-D-allofuranoside
• 英文别名: 5,6-di-O-isopropylidene-3-deoxy-3-(methoxycarbonyl-methyl)-α-D-allofuranoside；methyl 2-[(3aR,5S,6R,6aR)-5-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-6-yl]acetate
• CAS: 18427-18-4
• 化学式: C₁₅H₂₄O₇
• 分子量: 316.351
• InChiKey: JKCXVHKBWMZZHZ-QYGUOROXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.93
• 拓扑面积：
  72.4
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  1,2:5,6-di-O-isopropylidene-3-deoxy-3-(methoxycarbonyl-methyl)-α-D-allofuranoside 在 吡啶 、 溴 、 potassium carbonate 、 barium benzoate 、 三氟乙酸 作用下， 以 1,4-二氧六环 、 二氯甲烷 、 水 为溶剂， 生成 methyl (2R,3R,4S)-3-(2-phenylmethoxyethyl)-4-(phenylmethoxymethyl)oxetane-2-carboxylate
  参考文献：
  名称：

  Ring contraction of 3-deoxy-2-O-trifluoromethanesulphonates of α-hydroxy-γ-lactones to oxetanes

  摘要：

  DOI：

  10.1016/s0040-4039(00)97209-5
• 作为产物：
  描述：

  3-deoxy-3-C-[(Z)-(methoxycarbonyl)methylene]-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 生成 1,2:5,6-di-O-isopropylidene-3-deoxy-3-(methoxycarbonyl-methyl)-α-D-allofuranoside
  参考文献：
  名称：

  MULZER, JOHANN;STEFFEN, ULRICH;ZORN, LUDWIG;SCHNEIDER, CHRISTIAN;WEINHOLD+, J. AMER. CHEM. SOC., 110,(1988) N 14, 4640-4646

  摘要：

  DOI：

文献信息

• MONOSACCHARIDE DERIVATIVES
  申请人：Sattigeri Jitendra Viswajanani

  公开号：US20080114031A1

  公开（公告）日：2008-05-15

  The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disorder herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, Ulcerative colitis, acne, atherosclerosis, cancer, pruritis and allergic rhinitis. Pharmacological compositions containing compounds disclosed herein and the methods of treating bronchial asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis, type I diabetes, psoriasis, allograft rejection, inflammatory bowel disease, Ulcerative colitis, acne, atherosclerosis, cancer, pruritis, allergic rhinitis and other inflammatory and/or autoimmune disorders, using the compounds are also provided.

  本发明涉及单糖衍生物作为抗炎剂。本发明的化合物可用于抑制和预防炎症及相关病理，包括炎症和自身免疫疾病，如支气管哮喘、类风湿性关节炎、I型糖尿病、多发性硬化症、异体移植排斥、银屑病、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒和过敏性鼻炎。还提供了包含本发明披露的化合物的药物组合物，以及使用这些化合物治疗支气管哮喘、慢性阻塞性肺病、类风湿性关节炎、多发性硬化症、I型糖尿病、银屑病、异体移植排斥、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒、过敏性鼻炎以及其他炎症性和/或自身免疫障碍的方法。
• Monosaccharide Derivatives as Anti-Inflammatory and/or Anti-Cancer Agents
  申请人：Sattigeri Vishwajanani Jitendra

  公开号：US20090048186A1

  公开（公告）日：2009-02-19

  The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disorder herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, cancer, pruritis and allergic rhinitis. Pharmacological compositions containing compounds disclosed herein and the methods of treating bronchial asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis, type I diabetes, psoriasis, allograft rejection, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, cancer, pruritis, allergic rhinitis and other inflammatory and/or autoimmune disorders, using the compounds are also provided.

  本发明涉及单糖衍生物作为抗炎剂。本发明的化合物可用于抑制和预防炎症及相关病理，包括炎症和自身免疫疾病，如支气管哮喘、类风湿性关节炎、I型糖尿病、多发性硬化症、异体移植排斥、银屑病、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒和过敏性鼻炎。还提供了含有本发明披露的化合物的药物组合物，以及使用这些化合物治疗支气管哮喘、慢性阻塞性肺病、类风湿性关节炎、多发性硬化症、I型糖尿病、银屑病、异体移植排斥、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒、过敏性鼻炎以及其他炎症性和/或自身免疫障碍的方法。
• MONOSACCHARIDE DERIVATIVES AS ANTI-INFLAMMATORY AND/OR ANTI-CANCER AGENTS
  申请人：Ranbaxy Laboratories Limited

  公开号：EP1842855A3

  公开（公告）日：2007-12-05

  The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disorder herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, Ulcerative colitis, acne, atherosclerosis, cancer, pruritis and allergic rhinitis. Pharmacological compositions containing compounds disclosed herein and the methods of treating bronchial asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, psoriasis, allograft rejection, inflammatory bowel disease, Ulcerative colitis, acne, atherosclerosis, cancer, pruritis, allergic rhinitis and other inflammatory and/or autoimmune disorders, using the compounds are also provided.

  本发明涉及单糖衍生物作为抗炎药物。本文中所述的化合物可用于抑制和预防炎症及相关病理，包括支气管哮喘、类风湿关节炎、1型糖尿病、多发性硬化症、移植排斥、牛皮癣、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒和过敏性鼻炎等炎症和自身免疫性疾病。还提供了含有本文披露的化合物的药理组合物以及治疗支气管哮喘、慢性阻塞性肺病、类风湿关节炎、多发性硬化症、1型糖尿病、牛皮癣、移植排斥、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒、过敏性鼻炎和其他炎症和/或自身免疫性疾病的方法。
• Facially ControlledC-Methylation of Oxolanyl and Cyclopentyl Acetate Enolates: Application to the Total Synthesis of (+)-Nephromopsinic Acid
  作者：Johann Mulzer、Ulrich Steffen、Harry J. Martin、Ludwig Zorn

  DOI：10.1002/ejoc.200400653

  日期：2005.3

  The stereoselectivity of the C-methylation of oxolanyl and cyclopentyl acetate enolates 5a–22a was investigated. The configuration of the C-methyl diastereomers was elucidated by a combination of crystal structure analysis, NMR spectroscopy and chemical correlations. Generally, the methylation proceeded re*-selectively, although with very different degrees of selectivity. The most important stereodirecting

  研究了氧杂戊环和乙酸环戊酯烯醇化物 5a-22a 的 C-甲基化的立体选择性。C-甲基非对映异构体的构型通过晶体结构分析、核磁共振光谱和化学相关性的组合来阐明。通常，甲基化是重新选择性地进行的，尽管选择性程度非常不同。最重要的立体定向效应是由 5-苯乙基取代基产生的立体定向效应，并且这种立体定向效应因 3-OR 基团的立体定向效应而显着增强。与先前的文献证据相反，内环氧戊二烯基氧不发挥作用。这些发现被应用于 (+)-肾胞芘酸的高度立体选择性合成 (94)。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2005)
• Electrophilic additions to 3-C-[(methoxycarbonyl)methyl]-3-deoxy-D-ribofuranose enolates: a case of unusually efficient nonchelate-enforced chirality transfer
  作者：Johann. Mulzer、Ulrich. Steffen、Ludwig. Zorn、Christian. Schneider、Elmar. Weinhold、Winfried. Muench、Rainer. Rudert、Peter. Luger、Hans. Hartl

  DOI：10.1021/ja00222a024

  日期：1988.7

  Les halogenures d'alkyles et le benzaldehyde s'additionnent a l'enolate de lithium du compose du titre avec une diastereoselectivite superieure a 99%

  卤代烷烃和苯甲醛添加剂 a l'enolate delithium du compose du titre avec une diastereoselectivite superieure a 99%